An investigation for investors in NYSE:FMS shares over potential securities laws violations by Fresenius Medical Care AG & Co. was announced and NYSE:FMS stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 01/18/2017 --An investigation was announced for investors of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) shares over potential securities laws violations by Fresenius Medical Care AG & Co was announced.

Investors who purchased shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on concerning whether certain statements by Fresenius Medical Care AG & Co. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 7, 2017, Fresenius Medical Care AG & Co. reported that its U.S. unit had received subpoenas from federal prosecutors seeking information on the Company's ties with the American Kidney Fund, a charity that helps patients pay for kidney dialysis.

Shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) closed on January 17, 2017 at $40.93 per share.

Those who purchased shares of Fresenius Medical Care AG & Co. (ADR) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com